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ABSTRACT
Objective To explore the attitudes and perceptions 
of health professionals towards management of 
hypothyroidism that contributes to the suboptimal 
treatment of hypothyroidism in general practice.
Design A qualitative interview study using semistructured 
interviews.
Participants Sixteen participants were interviewed 
between March and August 2016 comprising nine general 
practitioners (GPs), four pharmacists, two practice nurses 
and one nurse practitioner.
Setting General practice and community pharmacies in 
the counties of Northumberland, Tyne and Wear, Stockton-
on-Tees and North Cumbria, North of England, UK.
Method A grounded-theory approach was used to 
generate themes from interviews, which were underpinned 
by the theory of planned behaviour to give explanation to 
the data.
Results Although health professionals felt that 
hypothyroidism was easy to manage, GPs and nurses 
generally revealed inadequate knowledge of medication 
interactions and levothyroxine pharmacokinetics. 
Pharmacists felt limited in the advice that they provide 
to patients due to lack of access to patient records. Most 
GPs and nurses followed local guidelines, and relied on 
blood tests over clinical symptoms to adjust levothyroxine 
dose. The information exchanged between professional 
and patient was usually restricted by time and often 
centred on symptoms rather than patient education. 
Health professionals felt that incorrect levothyroxine 
adherence was the main reason behind suboptimal 
treatment, although other factors such as comorbidity 
and concomitant medication were mentioned. Enablers 
perceived by health professionals to improve the 
management of hypothyroidism included continuity of 
care, blood test reminders, system alerts for interfering 
medications and prescription renewal, and accessible 
blood tests and levothyroxine prescriptions for patients.
Conclusion There is a signifi cant health professional 
behavioural component to the management of 
hypothyroidism. Addressing the differences in patient and 
professional knowledge and perceptions could reduce the 
barriers to optimal treatment, while continuity of care and 
increased involvement of pharmacists and practice nurses 
would help to promote optimal thyroid replacement.
INTRODUCTION 
Hypothyroidism is a common chronic disease 
caused by insufficient thyroid hormone 
production.1–3 Levothyroxine, a synthetic 
isomer of the thyroid hormone thyroxine, 
is used to treat hypothyroidism and is 
dispensed to 99.7% of patients with hypothy-
roidism in England.4 Dose increments are 
made following initiation of treatment to 
return serum thyroid-stimulating hormone 
(TSH) levels into the reference range5 and 
provide symptomatic relief.6 Without correc-
tion, patients with abnormal thyroid results 
may have an increased risk of cardiovascular 
disease, dysrhythmias and fractures,7 and are 
at risk of adverse effects on bone mass,8 lipid 
metabolism,9 blood pressure10 and cogni-
tive function.11 12 Even variation in thyroid 
function within the normal population 
Strengths and limitations of this study
 ► Suboptimal treatment of hypothyroidism in general 
practice is common, and behavioural approaches 
to treatment by health professionals involved in 
the management of patients with hypothyroidism 
warrant exploring.
 ► Confi dential discussions with health professionals 
in this study allowed for rich data of experiences, 
personal thoughts and perceptions of the 
management of hypothyroidism to be collected.
 ► A known potential limitation of qualitative research 
is the infl uence the researchers may have had in 
the process of data gathering and analysis, causing 
bias. However, to help reduce this limitation, the 
researcher who conducted the interviews did not 
have medical training, had not met the participants 
prior to the interviews or discussed the research 
with them.
 ► The small sample size of participants from the North 
of England may reduce the transferability of the 
fi ndings of this study to other contexts.
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reference range may also be associated with important 
differences in key health outcomes.13 14 Furthermore, 
neglected hypothyroidism can result in life-threatening 
myxoedema coma.15 Patients with overt hypothyroidism 
may experience low energy levels, cold intolerance, 
aches and pains, weight gain and changes in physical 
appearance.
The management of hypothyroidism is generally 
carried out in primary care and up until 2014, general 
practitioners (GPs) were required to maintain a register 
of patients with hypothyroidism as part of the Quality and 
Outcomes Framework (QOF). Hypothyroidism is consid-
ered a simple condition to manage16 and levothyroxine 
is well tolerated by the majority of patients.17 However, 
the therapeutic benefits of levothyroxine are sometimes 
unsatisfactory, and TSH levels higher than the reference 
range have been found in 11%–27% of patients receiving 
thyroid replacement therapy, while the prevalence of 
low TSH levels has been reported to range from 20% to 
41%.7 18–21
Compliance,22 23 pharmacogenomics associations24–28 
and interference from medication and comorbidities, 
such as autoimmune gastritis and coeliac disease,23 have 
all been found to have an effect on thyroid therapy and it is 
likely that there are multifactorial reasons for suboptimal 
treatment. However, only a limited number of studies to 
date have addressed potential solutions to suboptimal 
thyroid hormone replacement in general practice. To 
address this problem, we previously explored the atti-
tudes and perceptions of patients with hypothyroidism 
towards their treatment.29 In the present study, we have 
investigated the attitudes and perceptions towards the 
management of hypothyroidism among health profes-
sionals including GPs, nurse practitioners (NPs), phar-
macists and practice nurses. We sought to determine the 
clinical management and behavioural factors that may 
influence the adequacy of thyroid hormone replacement 
in patients with hypothyroidism.
METHOD
Design
Using a grounded theory approach,30 qualitative inter-
views were performed with health professionals to explore 
their experiences, attitudes and perceptions of the treat-
ment of hypothyroidism. Interviews were conducted by 
the same researcher (RD) and an initial semistructured 
topic guide was used (box 1). Themes from initial inter-
views were explored and developed in subsequent inter-
views, and were mapped to the constructs of the Theory of 
Planned Behaviour (TPB) to give an overall explanation 
of the data. The TPB describes the association between 
an individual’s beliefs and their behaviour by consid-
ering the influence of their attitude towards a particular 
behaviour, subjective norms and perceived behavioural 
control.31
Setting
Health professionals from general practice and commu-
nity pharmacies in the counties Northumberland, Tyne 
and Wear, Stockton-on-Tees and North Cumbria, North 
of England, were invited to take part. Interviews were 
conducted between March and August 2016.
Participants
Sixteen one-off interviews were conducted with nine GPs, 
four pharmacists (P), two practice nurses  (N) and one NP. 
Participants were recruited through the NIHR Clinical 
Research Network: North East and North Cumbria and 
local professional networks via mail and email, and partic-
ipants were given the option to contact the researcher if 
Box 1 Initial topic guide for interviews
What is your role in the management of patients with hypothyroidism?
Symptoms of hypothyroidism
 ► How would you describe your familiarity with the symptoms of 
hypothyroidism?
 ► Are you confi dent to spot patients with hypothyroidism? Why? 
Example?
 ► What makes you suspect hypothyroidism? Why? Example?
Diagnosis
 ► How would you describe your confi dence in making a diagnosis of 
hypothyroidism?
Referral
 ► Do you refer patients who have abnormal thyroid function tests? 
Can you describe the process?
 ► Do you refer patients to get a diagnosis of hypothyroidism?
 ► Who do you refer to? Can you describe the process?
Management
 ► What do you think about the management of hypothyroidism in 
general practice? Are you happy to manage hypothyroidism in 
general practice?
 ► How often do you check thyroid function tests?
 ► Does this differ for controlled/out of control patients?
 ► Are there any instances when you would refer/seek help? Example?
 ► How do you manage patients who complain of symptoms and 
the thyroid-stimulating hormone (TSH) are in the normal range? 
Example? Or would in theory? What are your thoughts on this?
 ► Do you fi nd it diffi cult to keep the TSH in the reference range?
 ► What do you think about changing levothyroxine dose for patients? 
Do you think the increments of 25 µg of levothyroxine too great?
 ► What are your thoughts about patients with hypothyroidism 
who are out of control? Are you concerned about patients with 
hypothyroidism who are out of control?
 ► What are your thoughts on patients with:
 – High TSH (usually indicating too little levothyroxine)?
 – Low TSH (usually indicating too much levothyroxine)?
 ► How do you manage patients who insist on taking more levothyroxine 
than their TSH suggests (ie, oversuppressed)?
 ► What do you think about patients who have high TSH blood tests 
which suggests that they are not taking enough levothyroxine? Have 
you experienced this?
 ► What are the main infl uences that you see that contribute to patients 
struggling to control their hypothyroidism?
 ► Can you predict which patients will struggle to control their 
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they wanted to take part. Most interviews were conducted 
face to face at the participant’s place of work or the 
University of Sunderland. However, due to participant 
availability, one GP was interviewed at home, and one GP 
was interviewed by telephone. Only the participant and 
the researcher were present during the interviews, and 
the researcher had not met the participants previously. 
Most participants were not known to each other; however, 
three pharmacists had lecturing roles at the University of 
Sunderland and were known to each other.
Confidentiality was assured, the process of the research 
explained and written consent was obtained prior to the 
interview. Interviews lasted approximately 45 min and 
interviewees were not paid for participation.
Sampling
Using purposive sampling, participants were recruited 
from both rural and urban areas to provide an initial 
maximum variation sample.30 To test emerging themes, 
theoretical sampling thereafter proceeded until data 
saturation was achieved and no new themes were 
forthcoming32 in the following two interviews. Data 
gathered from the interview with the NP was similar to 
that of the data obtained from the interviews with the 
practice nurses. Data saturation occurred quickly in 
the information provided by the interviews from our 
allied health professional group; thus, more GPs were 
recruited than other health professionals.
Analysis
Interviews were audio recorded and transcribed 
verbatim, and analysis was performed using Micro-
soft Word 2010. Open coding of transcripts preceded 
the categorisation of the data, and as the interviews 
progressed, themes emerging from the data were tested 
in subsequent interviews.33 Notes made by RD after 
the interviews were considering during analysis. Data 
analysis occurred concurrently with the interviews, 
and constant comparison and iterative analysis of the 
interview data allowed for development and remod-
elling of themes until data saturation was achieved.30 
Coding was performed by RD and in-depth data anal-
ysis and negotiation of themes were conducted by RD, 
KK and SW. Transcripts were returned to participants 
for comments and corrections; however, no feedback 
was received.
RESULTS
Participant characteristics are shown in table 1. Partici-
pant age ranged from 25 to 60 years, and 4 participants 
were men and 12 were women, with 6 participants working 
in rural areas and 10 working in urban areas. The three 
main themes that emerged from the data were perceived 
health professional control, perceived health professional 
responsibility and attitudes to thyroid control, which were 
underpinned to the TPB as shown in figure 1.
Perceived health professional control
Management of hypothyroidism
Generally health professionals found the management 
of hypothyroidism straightforward, relying on blood tests 
over non-specific clinical symptoms. However, there was 
uncertainty whether to start levothyroxine treatment in 
asymptomatic patients with borderline TSH levels, or 
patients with suggestive hypothyroid symptoms that did 
not have elevated TSH levels:
It’s relatively commonly and easily managed. And the 
medication is generally quite palatable for patients. 
And they largely feel better. (GP-1)
I think it’s something that we often go into a bit of 
autopilot because we rely more on blood tests. (GP-6)
Should you treat them or should you not? …we’ll 
just keep an eye on the blood test. The other side 
of the coin is that they get labelled and start having 
treatment for something when actually if you just left 
them alone they would have been fine. (GP-8)
Some health professionals recounted patients finding 
information on levothyroxine alternatives from online 
forums. Alternative treatments or referring to an endo-
crinologist was a last resort following the unsuccessful 
management of TSH with levothyroxine. Only a minority 
described alternatives including liothyronine (a synthetic 
form of triiodothyronine, T3), armour thyroid (desic-
cated porcine thyroid extract) and homeopathic alter-
natives. Health professionals had a tentative approach 
Table 1 Participant characteristics
Job role Location Age Gender Years qualified
General practitioner (GP)
  GP-1 Urban 45 Female 10
  GP-2 Rural 40 Male 14
  GP-3 Urban 59 Female 36
  GP-4 Urban 36 Female 10
  GP-5 Urban 39 Female 16
  GP-6 Urban 51 Male 27
  GP-7 Rural 52 Female 29
  GP-8 Rural 39 Female 14
  GP-9 Rural 48 Male 20
Nurse practitioner (NP)
  NP-1 Rural 55 Female 35
Practice nurse (N)
  N-1 Urban 58 Female 40
  N-2 Rural 60 Female 40
Community pharmacist (P)
  P-1 Urban 30 Male 8
  P-2 Urban 29 Female 6
  P-3 Urban 39 Female 15
  P-4 Urban 25 Female 2
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to levothyroxine alternatives, even with one example of 
a patient reporting feeling much better taking liothyro-
nine, despite TSH and T3 levels suggesting overtreatment:
People research it and they’ll come back and say, ‘I 
want the T3 because it’s better.’ (GP-2)
She is taking liothyronine… she had never felt better. 
But her TSH and her T3… suggest she’s being over-
treated. (NP)
Monitoring of hypothyroidism
Health professionals felt that blood test reminders and 
prescription renewal alerts were enablers of good thyroid 
management as were alerts to potentially interacting 
medication:
One of our admin team does a regular search and 
just finds out who’s out of date with their blood tests. 
(GP-7)
Because it's so good now, the computer system… 
Because it also alerts you if the doctors are prescribing 
something that interacts (N-2)
Access
Easy access to blood tests and electronic prescriptions 
were perceived by GPs to help patients access their 
levothyroxine; however, concern was raised that patients 
in nursing homes might not be as tightly monitored:
Electronic prescriptions and things have been help-
ful… not having the money, I guess, to get the bus up 
to pick up a prescription… we can send prescriptions 
electronically to the chemist. (GP-4)
We do have phlebotomy appointments in the evenings 
and weekends. (GP-7)
Continuity of care
Continuity of care was perceived by GPs to be important 
for the management of patients with hypothyroidism. 
Interpretation of normal thyroid function was difficult 
without matching patients’ expectations, symptoms and 
blood tests results:
So continuity of care does make a difference to pa-
tients who are difficult to manage or where compli-
ance is potentially a problem. Because if they start 
dotting all over the place, then you know you have to 
work that thread back up. And it’s all about trust. A 
lot of it is about trust in the GP. And that comes from 
continuity of care. (GP-1)
I think sometimes if blood test results are going back 
to a different [GP] than normally sees the patient, 
then it may just say ‘normal’. And there’s a risk that 
you would just say normal. (GP-7)
Pharmacists felt the advice they could give patients was 
limited by their lack of access to patient medical records, 
and that they could only advise depending on a patient’s 
account of their TSH results and medications. Pharma-
cists felt that access to TSH results would save time and 
inaccuracies in advice they give:
Figure 1 Concept diagram showing the attitudes and perceptions of health professionals towards the management of 
hypothyroidism in general practice.
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And that’s something that, you know, it would really 
help us if we had access to things like TSH results and 
things. Just as a second check, I think. (P-2)
Health professional knowledge
GPs and nurses felt they would need to check which medi-
cations may interact with levothyroxine, and it was gener-
ally perceived that their knowledge of hypothyroidism 
pharmacokinetics could be increased. Most health 
professionals felt that the GP had overall responsibility 
for knowledge acquisition:
I mean, off the top of my head, I actually couldn’t 
tell you any interactions between thyroxine… Apart 
from… I think it’s iron. (GP-8)
I suppose I haven't really taken the trouble to learn 
because I know that somebody else is doing it. (N-2)
GPs and pharmacists generally perceived that patient 
knowledge of thyroid function was basic. Pharmacists 
mostly felt that patients were unaware of the risk of under-
treatment or overtreatment with levothyroxine:
I don’t think many of them can really tell you what 
it’s for, what the thyroid does or what the risks are of 
going too high or too low. (P-1)
Perceived health professional responsibility
Provision of information
Generally health professionals provided verbal informa-
tion about hypothyroidism and the importance of blood 
tests. Pharmacists described the need to avoid multivita-
mins, iron containing drugs, calcium containing drugs, 
indigestion remedies and coffee. Health professionals 
generally did not explain the effects of hypothyroidism 
on the thyroid:
I’m not a leaflet person. I like to talk and tell them. 
And if I’ve got a visual aid, using the computer. I’ll 
explain to that. (NP-1)
Best in the morning. Not to take it [levothyroxine] 
with anything else—certainly not a cup of coffee. 
(P-3)
Generally, health professionals perceived that patients 
researched their own condition, or they would use leaflets 
from, or direct patients to  patient. co. uk:
These days I would generally tell people to look it up 
on the internet. And I would usually direct them to a 
website. These days, mainly  patient. co. uk. (GP-9)
You know, they’re quite happy, and they’ll often do 
research themselves. (GP-1)
Use of guidelines
Local guidelines were used by the majority of GPs, 
although many were reliant on the laboratory reference 
ranges. A few GPs felt that their management of hypothy-
roidism was not based on any guidelines:
I think that's all in the TRAMP [Thyroid Regional 
Assessment and Management Plan, NHS North of 
Tyne and Gateshead Area Prescribing Committee, 
North of England] guidelines. I think I try to follow 
what I'm meant to do. (GP-4)
I think the idea is just to try and get the result sit-
ting somewhere in that [laboratory reference range]. 
(GP-8)
You interpret the guidelines to treat the patient, not 
fitting the patient to the guideline. (GP-3)
Individualistic approach
Most GPs and nurses perceived that an individualistic 
approach was necessary for optimal thyroid hormone 
replacement for each patient. The general consensus was 
that GPs were happy to increase levothyroxine doses to 
make patients feel better as long as TSH levels remained 
within range:
I aim to get them within range and feeling okay. 
(GP-9)
I know there is evidence to suggest that you should 
keep them more to the suppressed end. If they’re in 
the parameters, to me, they are controlled. (NP-1)
Overtreatment with levothyroxine
Health professionals described the difficulty of attributing 
symptoms to thyroid disease when a levothyroxine-treated 
patient’s TSH remains in range:
But my instinct is that if you say you're unwell and 
your thyroid blood tests are normal, I don't think 
you're unwell because of your thyroid problem. I 
would be… I would be very reluctant to give some-
body extra thyroxine just in case. (GP-6)
GPs and nurses were conscious of the cardiac compli-
cations associated with giving a patient too much levothy-
roxine too quickly. Extra caution was described when 
treating the elderly where the risks of fractures may be 
high:
You need to be careful that you don’t suppress it too 
much, because that comes with some clinical risks 
around fractures—particularly in elderly patients. 
(GP-1)
Most GPs and the NP were not prepared to overtreat 
patients with levothyroxine due to the associated risks. 
One GP recounted that she had intentionally oversup-
pressed a patient’s TSH level, explaining that she knew 
the patient well; the patient had a good knowledge of 
their condition, was aware of the risks of oversuppression 
and was miserable on a lower dose. However, another GP 
felt that some colleagues choose to ignore over suppres-
sion of TSH:
And if that little old lady then falls over or fractures… 
And sues you, because you’ve, you know, artificially 
suppressed her TSH. (GP-1)
 on 9 July 2018 by guest. Protected by copyright.
http://bm
jopen.bm
j.com
/
BM
J Open: first published as 10.1136/bm
jopen-2017-019970 on 21 February 2018. Downloaded from
 
6 Dew R, et al. BMJ Open  2018;8:e019970. doi:10.1136/bmjopen-2017-019970
Open Access 
I felt that she was making an informed decision. She 
knew what the risks were. Especially as she got old-
er… being over-treated. (GP-3)
I've worked in a new practice, patients that have had 
TSH below 0.02 for a long time and they've just been 
told it's normal. (GP-5)
Reliability of hypothyroid symptoms
Health professionals had a good knowledge of hypothy-
roid symptoms and felt that if they knew the patient then 
developing slowness and change in mood made them 
suspect hypothyroidism. GPs felt that the symptoms of 
hypothyroidism were non-specific and overlapped with a 
number of clinical conditions. Moreover, health profes-
sionals perceived that patients often feel that their thyroid 
is accountable for many symptoms, particularly weight 
gain and tiredness:
So, you know, tiredness being one, weight gain being 
another, dry skin, intolerance to cold. But… Those 
are symptoms of lots of conditions, both physical 
health and mental health problems. (GP-1)
Once they’ve got a diagnosis of underactive thyroid, I 
think they blame it. (GP-2)
Attitudes to thyroid control
Responsibility
Health professionals felt that it was the patient’s respon-
sibility to attend blood tests, for good medication adher-
ence, and to challenge the GP if they were feeling 
symptomatic; however, it was perceived that the GP had 
overall responsibility:
I think it’s in partnership. Because if the patient 
doesn’t take the tablets, then you’re not going to get 
control… and you don’t check the blood tests and 
manage them appropriately, you’re not going to get 
good control. (GP-3)
Mainly the GP it’s their GP, who’s got the overall 
responsibility of looking after that patient. (NP-1)
Incorrect levothyroxine adherence as the main reason for 
suboptimal treatment
Some health professionals in our study felt that avoiding 
weight gain encouraged levothyroxine adherence in 
patients. Health professionals believed that poor adher-
ence was the main reason patients struggle to lower TSH 
levels. Additionally, the majority of health professionals 
said they had experienced a small proportion of patients 
who would take more levothyroxine than prescribed to 
alleviate tiredness or in an attempt to lose weight:
They think, oh, if I don’t take it, I’ll put even more 
weight on. So I think there is a lot of that going on. 
(N-2)
Certainly one patient I can remember who had said 
he had been feeling tired and have been taking an 
extra tablet. (P-1)
… likes to run his TSH low. And there is no arguing 
with him, because he will just take what he wants to 
take. He’ll come in and lie. (GP-8)
The priority of hypothyroidism
Health professionals believed patients may not priori-
tise hypothyroidism over health conditions such as heart 
disease, diabetes, hypertension and hypercholestero-
laemia, and hypothyroidism was not a routine focus of 
medication reviews. Removal of hypothyroidism from 
the QOF targets led to suspicions of reduced control and 
monitoring in some practices:
People who are on Dosette trays… they’re more con-
cerned about the other conditions that they have. 
(P-3)
There’s certain drugs that we get, sort of, payment for 
sitting down with patients and really going through 
how they work and how they should be taken. (P-2)
And it used to be a QOF target that each year they 
had to have an annual TSH, which was a very easy 
target to hit. And then it stopped about two years ago. 
So I think some practices, potentially, have sort of let 
their thyroid management drop. (GP-2)
Time restrictions
GPs and pharmacists felt that lack of time limited the 
information exchanged when speaking to a patient. One 
pharmacist felt there was pressure to focus on medica-
tion reviews, reducing the time available to give advice to 
other patients:
You’re always short of time. It’s always a problem. 
(GP-7)
They encourage us to do new services, such as medi-
cation use reviews and new medicine service reviews 
in pharmacies. We don’t necessarily have as much 
time as we would like to stand on the counter and 
talk to patients (P-1)
Concern over prioritising the busy GP workload 
was articulated, with thyroid function tests potentially 
accepted as being normal when they may not be:
And we’ve got an awful lot on our plates—using that 
old excuse again. But we’re really, really busy. And… 
Sometimes the blood results come through and 
you’re just like, well, actually they might have missed 
it for the last few days or whatever. And just bounce 
it through, you know. And then the patient… It’s on 
the patient’s head to ring up for their results and 
check that their levels are okay. (GP-8)
Factors that interact with treatment for hypothyroidism
GPs and pharmacists felt that if patients had an elevated 
TSH but reported that they were compliant then it 
may be due to other medication affecting the absorp-
tion of levothyroxine. Health professionals also felt that 
stress, diet, alcohol, coffee, smoking, having a busy life-
style, comorbidities, other medications, mental health, 
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learning disabilities, deafness and dementia could all 
have an effect on optimal thyroid hormone replacement:
So I guess when it’s [TSH] too high it’s usually like 
what I said before—are you taking your medication 
at all? Are there other reasons why it might be that 
you’re not absorbing it? Like the medication? Other 
conditions? (GP-4)
And I don’t think people had realised for many years, 
is the caffeine thing. And that’s the kind of thing that 
could come out in an MUR [medicine use review]. So 
are they drinking it with a cup of coffee in a morning? 
And calcium supplements as well. (P-3)
DISCUSSION
Principal findings
Regarding perceived professional control, health profes-
sionals felt that hypothyroidism was an easy condition to 
manage, and felt they relied on blood tests over non-spe-
cific clinical symptoms to confirm a diagnosis. However, 
health professionals generally perceived they had a lack 
of in-depth knowledge of medication interaction. On the 
other hand, pharmacists felt they could provide limited 
advice due to their lack of access to patient data and lack 
of time. Enablers perceived by health professionals to 
improve the management of hypothyroidism included 
continuity of care, reminders for blood tests, system alerts 
for medication interactions and prescription renewal, 
and easy access to blood tests and levothyroxine prescrip-
tions for patients.
In terms of perceived professional responsibility, 
most GPs and the NP followed local guidelines for 
the management of hypothyroidism, and would only 
increase the levothyroxine dose to improve symptom 
control as long as TSH levels remained within range. 
However, one GP recounted oversuppressing a patient 
at the patient’s request. The information exchanged 
between health professional and patient was limited by 
time restrictions, with most GPs and nurses assuming 
that patients would research their condition online. 
Written information leaflets were rarely provided to 
patients.
Attitudes to thyroid control included perceiving hypo-
thyroidism as less serious and more straightforward than 
other health conditions and that taking too much or 
too little levothyroxine was the main reason for inade-
quate thyroid control. However, interfering factors such 
as stress, other conditions and concomitant medication 
were acknowledged. GPs felt they were mainly responsible 
for a patient’s treatment, but stressed that good medica-
tion adherence by patients was important for optimal 
treatment.
Health professionals will usually strive to hold all atti-
tudes, beliefs and behaviours in harmony.34 However, this 
study has highlighted the cognitive dissonance between 
attitudes and beliefs versus behaviours that exist.
Comparisons with existing literature
Similar to the findings of our study, the management 
of hypothyroidism has been reported to be straightfor-
ward.16 Like the GPs in our study, continuity of care was 
described by GPs in a previous qualitative study to enable 
them to provide higher quality of care in general prac-
tice due to the personal relationships that had formed.35 
However, health professionals generally felt they had 
incomplete knowledge of hypothyroidism, which was also 
found for other diseases such as gout36 and dementia.37 
Access to patients medical records suggested by the 
pharmacists in this study has also been recommended 
to improve care and patient safety within Britain by the 
Royal Pharmaceutical Society.38 Including pharmacists 
in healthcare teams has been shown to reduce hospital 
admissions and medical costs of patients aged 80 years 
of age or older in Sweden,39 and pharmacist involvement 
has also been associated with lower rates of adverse drug 
events.40
Deliberate TSH suppression (<0.1 mU/L) with 
high doses of levothyroxine, which was avoided by the 
majority of GPs in our study, is not recommended due 
to the potential risk of heart disease, stroke, osteoporosis 
and fractures.41 In our previously published work with 
patients with hypothyroidism, patients felt that health 
professionals were more inclined to treat their TSH levels 
than their symptoms and that they were not given very 
much information at the time of diagnosis,29 as reported 
by some health professionals in this study.
Time was a barrier to thyroid management identified 
by health professionals in our study, and is a well-docu-
mented limitation in primary care.42 43 However, previous 
studies have shown that although time is a limitation in 
terms of the information exchanged, it is consultation 
quality rather than the length of appointment that is 
more impactful.43 Poor levothyroxine adherence, medi-
cation interactions and comorbidities have been reported 
to have an effect on thyroid replacement therapy,44 which 
were some of the barriers reported in this study. However, 
in our qualitative interview study with patients with hypo-
thyroidism, although not generalisable outside of the 
patient population, good levothyroxine adherence was 
reported by nearly all patients, even those who had TSH 
levels outside of the reference range,29 suggesting that the 
reasons for inadequate thyroid treatment may lie deeper 
than the typical assumptions by health professionals that 
poor adherence is the main reason for suboptimal treat-
ment.22 23
Strengths and weaknesses
Due to time restrictions of this research project, this study 
did not have the opportunity to be pilot tested, which may 
have affected how the interviews progressed. Moreover, 
no feedback on the transcripts was provided by partici-
pants; feedback may have contributed to enriching the 
data further. Open coding was performed by RD; however, 
negotiation of categories and themes were conducted by 
RD, KK and SW to help reduce this limitation.
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Since our sample only included four pharmacists and 
three nurses, the evidence presented from these groups 
may lack validity and generalisability outside of this small 
sample size. Moreover, a different sample of participants 
with different levels of experience may have provided 
different results, particularly pharmacists with more years 
of experience, and also from rural areas. Additionally, 
within our GP sample, it was unknown whether those who 
took part in our study were more likely to follow guide-
lines and regularly review patients, thus being less likely 
to have higher numbers of thyroxine-treated patients 
with abnormal TSH than those who did not take part in 
our study. However, although this study was conducted 
with a sample of 16 participants in the North of England, 
and may not be generally applicable, the findings are 
transferrable within this professional population, and this 
study provides novel insights into the attitudes, experi-
ences and behaviour of health professionals involved in 
the management of hypothyroidism.
Implications for future research and clinical practice
To help increase perceived health professional control in 
the future, quantifying the extent that clinical, behavioural 
and pharmacogenomic associations may affect levothy-
roxine therapy and providing this information to health 
professionals involved in management of hypothyroidism 
may improve management and therefore treatment for 
this group of patients. However, it should be considered 
that health professionals in general practice have limited 
time and specialism. Moreover, increasing the involve-
ment of pharmacists or practice nurses in the manage-
ment of hypothyroidism may improve their perceived 
control and help relieve the pressure on GPs, and may 
also increase continuity of care, for example, through 
pharmacist-led medication reviews or specific chronic 
disease management clinics for this cohort of patients.
To reinforce perceived health professional responsi-
bility, consistent provision of patient information leaflets 
and discussions about hypothyroidism would help increase 
patient understanding and this type of information can 
be exchanged in a short period of time, and may reduce 
the time pressures on GPs if patients are more informed. 
Finally, clarity on the timing of initiation of treatment in 
asymptomatic patients with slightly elevated TSH, and an 
age specific and symptom focus where appropriate may 
help to improve the management of patients with hypo-
thyroidism within general practice.
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